You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Antineoplastic agents/Adverse effects

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Reporting of AdVerse Events Associated With AnTicAncerRapy

Recruiting
  • Cancer
  • Antineoplastic and Immunomodulating Agents
  • Caen, Basse Normandie, France
    Alexandre Joachim
Jan 4, 2021

Breast Cancer, Gynecologic Cancer, HNSCC Trial in Boston (STX-478, Fulvestrant)

Recruiting
  • Breast Cancer
  • +3 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Mar 13, 2023

Carcinoma, Intrahepatic Cholangiocarcinoma, Gallbladder Cancer Trial (HAIC, Surufatinib, Tislelizumab)

Not yet recruiting
  • Carcinoma
  • +7 more
  • (no location specified)
Nov 12, 2023

Tumors, Carcinoma, Squamous, Antineoplastic Agents Trial (Nivolumab Injection [Opdivo])

Not yet recruiting
  • Neoplasms
  • +2 more
  • Nivolumab Injection [Opdivo]
  • (no location specified)
Jul 19, 2023

Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma Trial in

Recruiting
  • Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma
  • Columbus, Ohio
  • +9 more
Aug 1, 2022

Reporting of Antibody-Drug Conjugate Associated Sepsis-related

Completed
  • Sepsis (SMQ)
  • +2 more
  • Antibody-Drug Conjugate
  • Antineoplastic and immunomodulating agents other than Antibody-Drug Conjugate
  • Changsha, Hunan, China
    Central South University
Jun 19, 2022

Anticholinergic Burden On Daily Living Activities In Elderly

Not yet recruiting
  • Anticholinergic Syndrome
  • +5 more
    • (no location specified)
    Jun 13, 2023

    Tumors, Kidney Tumors, Urologic Tumors Trial in Nanjing (Toripalimab, Axitinib, Lenvatinib)

    Recruiting
    • Neoplasms
    • +12 more
    • Nanjing, Jiangsu, China
      Jinling Hospital, Affiliated Hospital of Medical School, Nanjing
    Oct 28, 2023

    NSCLC, Antineoplastic Agents Trial in Edmonton (Experimental intervention)

    Active, not recruiting
    • Carcinoma, Non-Small-Cell Lung
    • Antineoplastic Agents
    • Experimental intervention
    • Edmonton, Alberta, Canada
      Cross Cancer Institute
    May 23, 2022

    Carbetocin, Oxytocic Drugs Causing Adverse Effects in Therapeutic Use Trial in Bornova (C-sections operations, Oxytocin,

    Not yet recruiting
    • Carbetocin
    • Oxytocic Drugs Causing Adverse Effects in Therapeutic Use
    • C-sections operations
    • +2 more
    • Bornova, İ̇zmi̇r, Turkey
      EÜTF
    Feb 14, 2023

    Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in United States (CYNK-001)

    Recruiting
    • Leukemia
    • +19 more
    • CYNK-001
    • Denver, Colorado
    • +9 more
    Sep 9, 2022

    Reporting of Cardio-vascular Adverse Events With Antineoplastic

    Unknown status
    • Cardiac Disease
    • Cancer
    • Antineoplastic and Immunomodulating Agents
    • Paris, France
      AP-HP, Pitié-Salpêtrière Hospital,Department of Pharmacology, CI
    Sep 2, 2019

    IBD, Biological Substance; Adverse Effect Trial in Haifa (Azithromycin Pill, Placebo)

    Not yet recruiting
    • Inflammatory Bowel Diseases
    • Biological Substance; Adverse Effect
    • Azithromycin Pill
    • Placebo
    • Haifa, Israel
      Rambam Health Care Campus
    Oct 25, 2022

    GHB Poisoning and Poisoning Induced by Others

    Recruiting
    • Drug Toxicity
      • Oslo, Norway
        University of Oslo, Institute of Health and Society
      Nov 8, 2022

      Falls in Older Adults: Analysis of World Health Organization

      Completed
      • Antidepressants Causing Adverse Effects in Therapeutic Use
      • Fall
      • Antidepressive Agents
      • Caen, Normandie, France
        Caen University Hospital, Department of Pharmacology
      Nov 24, 2022

      Ocular Adverse Events in Neovascular Age-related Macular

      Completed
      • Age-related Macular Degeneration (AMD)
      • Aflibercept
      • +2 more
      • East Hanover, New Jersey
        Novartis Investigative Site
      Dec 15, 2021

      Ocular Adverse Events in Neovascular Agerelated Macular

      Completed
      • Age-related Macular Degeneration (AMD)
      • Aflibercept
      • +2 more
      • East Hanover, New Jersey
        Novartis Investigative Site
      Dec 15, 2021

      Multiple Myeloma, Tumor, Plasma Cell, Tumors by Histologic Type Trial in United States (CYNK-001)

      Active, not recruiting
      • Multiple Myeloma
      • +19 more
      • CYNK-001
      • Denver, Colorado
      • +8 more
      May 24, 2022

      Urinary Bladder Tumors, Urologic Tumors, Urogenital Tumors Trial in Shanghai (tislelizumab and BCG)

      Recruiting
      • Urinary Bladder Neoplasms
      • +5 more
      • tislelizumab and BCG
      • Shanghai, Shanghai, China
        Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong Universi
      Jun 10, 2021

      CIPN and it's Impact on Quality of Life in Patients Receiving

      Not yet recruiting
      • Chemotherapy-induced Peripheral Neuropathy
        • (no location specified)
        Apr 24, 2023

        Leukemia, Myeloid, Acute, MDS Trial in Worldwide (CC-95251, Azacitidine)

        Recruiting
        • Leukemia, Myeloid, Acute
        • Myelodysplastic Syndromes
        • Marina Del Rey, California
        • +35 more
        Mar 11, 2022

        Hormone Receptor Positive Breast Carcinoma, Breast Tumors, Tumors, Breast Trial in Italy (Liquid biopsy and CT scan)

        Recruiting
        • Hormone Receptor Positive Breast Carcinoma
        • +6 more
        • Liquid biopsy and CT scan
        • Bergame, Bergamo, Italy
        • +6 more
        Apr 13, 2023

        Severe Checkpoint Inhibitor Pneumonitis Trial in Beijing (Corticosteroids, Corticosteroids and Ruxolitinib)

        Recruiting
        • Severe Checkpoint Inhibitor Pneumonitis
        • Beijing, Beijing, China
          Department of Respiratory Medicine, Peking Union Medical College
        Jun 12, 2023

        Responsible Side Effects Management in Oncology

        Completed
        • Pharmacovigilance
        • +2 more
          • Zagreb, Croatia, Europe, Croatia
            UHC Sestre milorsdnice
          Nov 4, 2020

          Lung Tumor Malignant, NSCLC, Respiratory Tract Tumors Trial in United States (BLU-451)

          Recruiting
          • Lung Neoplasm Malignant
          • +18 more
          • Fairfax, Virginia
            New Experimental Therapeutics of Virginia (NEXT Oncology)
          Mar 29, 2022